Pathology of coronary microembolisation and no reflow

Heart

Volumn 89, Issue 9, 2003, Pages 983-985

  Falk, Erling ^a   Thuesen, L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL EMBOLISM; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; HUMAN; IATROGENIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; THROMBOSIS;

EID: 0041326895     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.9.983     Document Type: Conference Paper

References (16)

1. Davies MJ. The pathophysiology of acute coronary syndromes [review]. Heart 2000;83:361-6.
2. Falk E. Stable versus unstable atherosclerosis: clinical aspects [review]. Am Heart J 1999;138(5 Pt 2):5421-5.
3. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention [review]. Circulation 1998;97:916-31.
4. Falk E. Fatal atherosclerosis developed in less than 4 years in an aortocoronary vein graft in a hyperlipidemic patient. Acta Pathol Microbiol Immunol Scand [A] 1984;92:73-5.
5. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease [review]. Circulation 2000;101:570-80.
6. Heusch G, Schulz R, Baumgart D, et al. Coronary microembolization [review]. Prog Cardiovasc Dis 2001;44:217-30.
7. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985;71:699-708.
8. Davies MJ, Thomas AC, Knapman PA, et al. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 1986;73:418-27.
9. Frink RJ, Rooney PA, Trowbridge JO, et al. Coronary thrombosis and platelet/fibrin microemboli in death associated with acute myocardial infarction. Br Heart J 1988;59:196-200.
10. Roffi M, Chew DP, Mukherjee D, et al. Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy. Eur Heart J 2002;23:1441-8.
11. Mehran R, Dangas G, Mintz GS, et al. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients. Circulation 2000;101:604-10.
12. Reffelmann T, Kloner RA. The "no-reflow" phenomenon: basic science and clinical correlates [review]. Heart 2002;87:162-8.
13. Reffelmann T, Kloner RA. Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol 2002;283:H1099-107.
14. Montalescot G. Defining standards of care for facilitated and direct percutaneous coronary intervention [review]. Clin Cardiol 2002;25(suppl 1), 1-27-32.
15. Baim DS, Wahr D, George B, et al for the Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial investigators. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-90.
16. Roffi M, Mukherjee D, Chew DP, et al. Lack of benefit from intravenous piatelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials. Circulation 2002;106:3063-7.